ADAR1 Capital Management »

Sensient Technologies Corporation shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Sensient Technologies Corporation (SXT) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Sensient Technologies Corporation

Tip: Access up to 7 years of quarterly data

All positions including Sensient Technologies Corporation held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensient Technologies Corporation by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 15k 86.44

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Terns Pharmaceuticals Call Option (TERN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Crinetics Pharmaceuticals In (CRNX)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Denali Therapeutics (DNLI)
Beam Therapeutics (BEAM)
Zai Lab Adr (ZLAB)
Septerna (SEPN)
Vir Biotechnology (VIR)
Dbv Technologies S A Sponsored Ads (DBVT)

View all positions for ADAR1 Capital Management

Top funds holding Sensient Technologies Corporation

Freemont Capital Pte
BlackRock
Vanguard Group
Vanguard Portfolio Management
Vanguard Capital Management
Henderson Group
State Street Corporation
Westwood Holdings
Dimensional Fund Advisors
Geode Capital Management
Vaughan Nelson Investment Management
Congress Asset Management
Snyder Capital Management
Victory Capital Management
Charles Schwab Investment Management

View all funds holding Sensient Technologies Corporation